ReviewPharmaceuticals (Basel, Switzerland)2023

Recombinant Endostatin as a Potential Radiosensitizer in the Treatment of Non-Small Cell Lung Cancer.

Charnay Cunningham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.